Skip to content
by IQAC KIITKIIT Deemed to be University — Internal Quality Assurance Cell

Publication2023

Nanocarrier vaccine therapeutics for global infectious and chronic diseases

The record

Type
Publication
Date
1 June 2023
Level
International — held abroad
Journal
Materials Today
Volume
66
Pages
371-408
Published
1 June 2023
DOI
10.1016/j.mattod.2023.04.008
Scopus ID
85153950259
ISSN
13697021
Authors
9
Open access
Yes
Citations
36
International co-authorship
Yes
Co-author countries
IN, KR, SE

Classification

Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.

UN Sustainable Development Goals

  1. 3 Ensure healthy lives and promote well-being for all at all ages

    GoalPrimaryHigh confidenceJudged

    Nanocarrier vaccine development for COVID-19, HIV, malaria, TB, and influenza directly supports immunization and pandemic prevention for global health.

    High confidence
    The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
    Judged
    Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

  2. 12 Ensure sustainable consumption and production patterns

    GoalSecondaryModerate confidenceJudged

    Nanoparticle encapsulation of antigens and functional vaccine platforms reduce chemical waste and support sustainable therapeutic development.

    Moderate confidence
    The alignment is plausible and defensible but rests on an assumption a reasonable reviewer could decline. Published, and surfaced in the review queue for a human to confirm or override.
    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

  3. 17.6 Enhance North-South, South-South and triangular cooperation on science, technology and innovation, and knowledge sharing

    TargetSecondaryHigh confidenceRule-derivedrule sdg17-structural-v1

    Structural signal: co-authorship outside India.

    Rule-derived
    Emitted by a deterministic rule from structural signals rather than judged from the record’s text. The rule carries a version, so rule-derived and judged labels stay separable.
    Produced by
    sdg17-structural-v1, under kortex-publication-v1

Viksit Bharat @2047

  1. vb-1.2 Health and well-being

    Sub-themePrimaryHigh confidenceJudged

    Nanovaccine therapeutics for infectious disease prevention and health outcomes directly align with Viksit Bharat health and well-being advancement.

    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

Each label above carries the instrument and the version that produced it. How each classification is reached.

Evidence

Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.

No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.

Provenance

Which source system this record came from, how many source rows were resolved into it, and when each was last read.

Source rows resolved into this record
1

Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.

Citing this record

This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.

KIIT Deemed to be University. “Nanocarrier vaccine therapeutics for global infectious and chronic diseases”. Kortex.

Explore the full record

Nanocarrier vaccine therapeutics for global infectious and chronic diseases · Kortex